Osteoremedies LLC

Osteoremedies LLC, a for-profit limited liability company headquartered in Germantown, Tennessee, supplies orthopedic surgical implants and prosthetic devices to the Department of Veterans Affairs and the Department of Defense as a prime contractor competing in the open market with no set-aside designations across its entire 201-award footprint.

Osteoremedies manufactures and delivers knee replacement components (tibial stemmed, femoral, and revision systems), hip revision and replacement implants, shoulder implants and humeral heads, antibiotic joint spacer systems, femoral stem implants, prosthetic limbs, and surgical implant screws. Representative work includes a $16,255 firm fixed-price purchase order from VISN 17 for knee revision tibial stemmed components (April 2026), a $24,690 purchase order from VISN 20 for custom surgical implants (February 2026), a $35,220 purchase order from the Defense Health Agency for a Remedy Shoulder Spacer System (May 2024), and a $26,000 purchase order from the Defense Health Agency for an antibiotic treatment plan system (May 2023). All work is structured as firm fixed-price purchase orders with individual ceiling values typically ranging from $10,000 to $27,000, reflecting small-order medical device supply arrangements rather than large program contracts.

Customer concentration is marked and narrowly focused on VA regional hospital networks. The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 dominates the portfolio with 46 awards worth $612 thousand combined potential value; VISN 22 accounts for 27 awards worth $331 thousand; the Department of the Army Medical Command holds 20 awards worth $459 thousand; VISN 17 carries 19 awards worth $261 thousand; and VISN 19 shows 15 awards worth $177 thousand. Together, these five customers represent 63% of all awards and 66% of combined potential value. Osteoremedies has worked across 21 distinct customer agencies, but the VA VISNs and Army Medical Command absorb the vast majority of its portfolio. The vendor has no subcontract activity and operates entirely as a prime supplier.

Activity has remained consistent and modest in scale. The vendor recorded 22 awards in 2022, 23 in 2023, 33 in 2024, 24 in 2025, and 2 awards through mid-2026. Combined potential value across all 201 awards is $2.8 million, with 100% of that amount obligated. The recompete cliff over the next twenty-four months includes only 2 awards with a combined potential value of $41 thousand, indicating minimal near-term competitive exposure.

The vendor's work is categorized under NAICS 336211 (Surgical Appliance and Supplies Manufacturing) for 166 awards, with 28 awards under Surgical and Medical Instrument Manufacturing. Federal Procurement Classification is dominated by Medical and Surgical Instruments, Equipment, and Supplies (PSC 6525, 197 awards), with sparse activity in Surgical Dressing Materials and Imaging Equipment.

Osteoremedies operates as a niche medical device supplier to federal healthcare systems, competing in full-and-open purchase order competitions without SBA set-asides. The business model centers on direct supply relationships with individual VA VISNs and Army Medical Command rather than prime contracting vehicles, IDIQs, or larger government-wide agreements.